Animal models of motor neuron death

Handbook of Clinical Neurophysiology

Volumn 4, Issue C, 2004, Pages 201-218

  Julien, Jean Pierre ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957084964     PISSN: 15674231     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-4231(04)04010-9     Document Type: Article

References (114)

1. Ahlijanian M.K., Barrezueta N.X., Williams R.D., Jakowski A., Kowsz K.P., McCarthy S., Coskran T., Carlo A., Seymour P.A., Burkhardt J.E., Nelson R.B., and McNeish J.D. Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci USA 97 (2000) 2910-2915
2. Al-Chalabi A., Andersen P.M., Nilsson P., Chioza B., Andersson J.L., Russ C., Shaw C.E., Powell J.F., and Leigh P.N. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum. Mol. Genet 8 (1999) 157-164
3. Almer G., Vukosavic S., Romero N., and Przedborski S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem 72 (1999) 2415-2425
4. Angelov D.N., Waibel S., Gutinas-Lichius O., Lenzen M., Neiss W.F., Tomov T.L., Yoles E., Kipnis J., Schori H., Reuter A., Ludolph A., and Schwartz M. Therapeutic vaccine for acute and chronic motor neuron disease: Implications for amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA (2003)
5. Bajaj N.P., Al-Sarraj S.T., Anderson V., Kibble M., Leigh N., and Miller C.C. Cyclin-dependent kinase-5 is associated with lipofuscin in motor neurones in amyotrophic lateral sclerosis. Neurosci. Lett 245 (1998) 45-48
6. Barneoud P., and Curet O. Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis. Exp. Neurol 155 (1999) 243-251
7. Beaulieu J.M., and Julien J.P. Peripherin-mediated death of motor neurons rescued by overexpression of neurofilament NF-H proteins. J. Neurochem 85 (2003) 248-256
8. Beaulieu J.M., Nguyen M.D., and Julien J.-P. Late onset death of motor neurons in mice overexpressing wild-type peripherin. J. Cell. Biol 147 (1999) 531-544
9. Beaulieu J.M., Jacomy H., and Julien J.-P. Formation of intermediate filament protein aggregates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit. J. Neurosci 20 (2000) 5321-5328
10. Beckman J.S., and Crow J.P. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans 21 (1993) 330-334
11. Beckman J.S., Carson M., Smith C.D., and Koppenol W.H. ALS, SOD and peroxynitrite. Nature 364 (1993) 584
12. Bian F., Nath R., Sobocinski G., Booher R.N., Lipinski W.J., Callahan M.J., Pack A., Wang K.K., and Walker L.C. Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice. J. Comp. Neurol 446 (2002) 257-266
13. Bommel H., Xie G., Rossoll W., Wiese S., Jablonka S., Boehm T., and Sendtner M. Missense mutation in the tubulin-specific chaperone E (Tbce) gene in the mouse mutant progressive motor neuronopathy, a model of human motoneuron disease. J. Cell Biol 159 (2002) 563-569
14. Bordet T., Lesbordes J.C., Rouhani S., Castelnau-Ptakhine L., Schmalbruch H., Haase G., and Kahn A. Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice. Hum. Mol. Genet 10 (2001) 1925-1933
15. Brion J.P., and Couck A.M. Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. Am. J. Pathol 147 (1995) 1465-1476
16. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., and Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18 (1997) 327-338
17. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., and Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281 (1998) 1851-1854
18. Clement A.M., Nguyen M.D., Roberts E.A., Doucette W., Ferrante R., McMahon A., Brown R.H.J., Julien J.-P., Goldstein L.S.B., and Cleveland D.W. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302 (2003) 113-117
19. Cleveland D.W. From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. Neuron 24 (1999) 515-520
20. Corbo M., and Hays A.P. Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease. J. Neuopathol. Exp. Neurol 51 (1992) 531-537
21. Cote F., Collard J.F., and Julien J.-P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 73 (1993) 35-46
22. Couillard-Després J.-S., Zhu Q., Wong P.C., Price D.L., Cleveland D.W., and Julien J.-P. Protective effect of neurofilament NF-H overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl Acad. Sci. USA 95 (1998) 9626-9630
23. De Jonghe P., Mersiyanova I.V., Nelis E., Del Favero J., Martin J.J., Van Broeckhoven C., Evgrafov O.V., and Timmerman V. Further evidence that neurofilament light chain mutations can cause Charcot-Marie Tooth disease type 2E. Ann. Neurol 49 (2001) 245-249
24. Drachman D.B., Frank K., Dykes-Hoberg M., Teismann P., Almer G., Przedborski S., and Rothstein J.D. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol 52 (2002) 771-778
25. Durham H.D., Roy J., Dong L., and Figlewicz D.A. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J. Neuropathol. Exp. Neurol 56 (1997) 52-56
26. Echeverri C.J., Paschal B.M., Vaughan K.T., and Vallee R.B. Molecular characterization of the 50-kD subunit of dynactin reveals function for the complex in chromosome alignment and spindle organization during mitosis. J. Cell Biol 132 (1996) 617-633
27. Elder G.A., Friedrich Jr. V.L., Kang C., Bosco P., Gourov A., Tu P.H., Zhang B., Lee V.M., and Lazzarini R.A. Requirement of heavy neurofilament subunit in the development of axons with large calibers. J. Cell Biol 143 (1998) 195-205
28. Elder G.A., Friedrich Jr. V.L., Margita A., and Lazzarini R.A. Age-related atrophy of motor axons in mice deficient in the mid-sized neurofilament subunit. J. Cell Biol 146 (1999) 181-192
29. Facchinetti F., et al. Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis. Neuroscience 90 (1999) 1483-1492
30. Figlewicz D.A., Krizus A., Martinoli M.G., Meininger V., Dib M., Rouleau G.A., and Julien J.-P. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet 3 (1994) 1757-1761
31. Friedlander R.M., Brown R.H., Gagliardini V., Wang J., and Yuan J. Inhibition of ICE slows ALS in mice. Nature 388 (1997) 31
32. Giasson B.I., Duda J.E., Quinn S.M., Zhang B., Trojanowski J.Q., and Lee V.M. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34 (2002) 521-533
33. Gong Y.H., Parsadanian A.S., Andreeva A., Snider W.D., and Elliott J.L. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci 20 (2000) 660-665
34. Groeneveld G.J., Veldink J.H., and van der Tweel I. A randomized sequential trial of creatine monohydrate in amyotrophic lateral sclerosis. Ann. Neurol 53 (2003) 437-445
35. Gurney M.E., Cutting F.B., Zhai P., Doble A., Taylor C.P., Andrus P.K., and Hall E.D. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol 39 (1996) 147-157
36. Gurney M.E., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
37. Gurney M.E., Fleck T.J., Himes C.S., and Hall E.D. Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis. Neurology 50 (1998) 62-66
38. Hadano S., Hand C.K., Osuga H., Yanagisawa Y., Otomo A., Devon R.S., Miyamoto N., Showguchi-Miyata J., Okada Y., Singaraja R., Figlewicz D.A., Kwiatkowski T., Hosler B.A., Sagie T., Skaug J., Nasir J., Brown Jr. R.H., Scherer S.W., Rouleau G.A., Hayden M.R., and Ikeda J.E. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet 29 (2001) 166-173
39. Hall E.D., Oostveen J.A., and Gurney M.E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23 (1998) 249-256
40. Houseweart M.K., and Cleveland D.W. Bcl-2 overexpression does not protect neurons from mutant neurofilament-mediated motor neuron degeneration. J. Neurosci 19 (1999) 6446-6456
41. Howland D.S., Liu J., She Y., Goad B., Maragakis N.J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., DeGennaro L.J., Cleveland D.W., and Rothstein J.D. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad. Sci. USA 99 (2002) 1604-1609
42. Hirano A., Nakano I., Kurland L.T., Mulder D.W., Holley P.W., and Saccomanno G. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol 43 (1984) 471-480
43. Ishihara T., Hong M., Zhang B., Nakagawa Y., Lee M.K., Trojanowski J.Q., and Lee V.M. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24 (1999) 751-762
44. Ishihara T., Higuchi M., Zhang B., Yoshiyama Y., Hong M., Trojanowski J.Q., and Lee V.M. Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments. J Neurosci 21 (2001) 6026-6035
45. Jacomy H., Zhu Q., Couillard-Despres S., Beaulieu J.M., and Julien J.P. Disruption of type IV intermediate filament network in mice lacking the neurofilament medium and heavy subunits. J. Neurochem 73 (1999) 972-984
46. Johnston J.F., Dalton M.J., Gurney M.E., and Kopito R.R. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 97 (2000) 12571-12576
47. Julien J.P. Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded. Cell 104 (2001) 581-591
48. King S.J., and Schroer T.A. Dynactin increases the processivity of the cytoplasmic dynein motor. Nat. Cell Biol 2 (2000) 20-24
49. Klivenyi P., Ferrante R.J., Matthews R.T., Bogdanov M.B., Klein A.M., Andreassen O.A., Meuller G., Wermer M., Kaddurah-Daouk R., and Beal M.F. Neuroprotective effects of creatin in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med 5 (1999) 347-350
50. Knudsen E.S., and Wang J.Y.J. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol. Cell. Biol 17 (1997) 5771-5783
51. Kong J., and Xu Z. Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis. Neurosci. Lett 281 (2000) 72-74
52. Kostic V., Jackson-Lewis V., De Bilbao F., Dubois-Dauphin M., and Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277 (1997) 559-562
53. Kriz J., Meier J., Julien J.-P., and Padjen A.L. Altered ionic conductances in axons of transgenic mice expressing the human neurofilament heavy gene. Exp. Neurol 163 (2000) 414-421
54. Kriz J., Zhu Q., Julien J.P., and Padjen A.L. Electrophysiological properties of axons in mice lacking neurofilament subunit genes: disparity between conduction velocity and axon diameter in absence of NF-H. Brain Res 885 (2000) 32-44
55. Kriz J., Nguyen M.D., and Julien J.P. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis 10 (2002) 268-278
56. Kriz J., Gowing G., and Julien J.P. Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Ann. Neurol 53 (2003) 429-436
57. LaMonte B.H., Wallace K.E., Holloway B.A., Shelly S.S., Ascano J., Tokito M., Van Winkle T., Howland D.S., and Holzbaur E.K. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34 (2002) 715-727
58. Larivière R., Nguyen M.D., Ribeiro-da-Silva A., and Julien J.-P. Reduced Number of Unmyelinated Sensory Axons in Peripherin Null Mice. J. Neurochem 81 (2002) 525-532
59. Larivière R., Beaulieu J.-M., Nguyen M.D., and Julien J.-P. Peripherin is not a contributing factor to motor neuron disease in a mouse model of ALS caused by mutant superoxide dismutase. Neurobiol. Dis 13 (2003) 158-166
60. Lee M.S., Kwon Y.T., Li M., Peng J., Friedlander R.M., and Tsai L.H. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405 (2000) 360-364
61. Lee M.K., Marszalek J.R., and Cleveland D.W. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 13 (1994) 975-988
62. Lee V.M., Goedert M., and Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci 24 (2001) 1121-1159
63. Levavasseur F., Zhu Q., and Julien J.P. No requirement of alpha-internexin for nervous system development and for radial growth of axons. Brain Res. Mol. Brain Res 69 (1999) 104-112
64. Li M., Ona V.O., Guegan C., Chen M., Jackson-Lewis V., Andrews L.J., Olszewski A.J., Stieg P.E., Lee J.P., Przedborski S., and Friedlander R.M. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288 (2000) 335-339
65. Liu D.X., and Greene L.A. Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res 305 (2001) 217-228
66. Lino M.M., Schneider C., and Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci 22 (2002) 4825-4832
67. Martin N., Jaubert J., Gounon P., Salido E., Haase G., Szatanik M., and Guenet J.L. A missense mutation in Tbce causes progressive motor neuronopathy in mice. Nat Genet 32 (2002) 443-447
68. Meier J., Couillard-Després S., and Julien J.-P. Extra neurofilament NF-L proteins rescue motor neuron disease caused by overexpression of human NF-H in mice. J. Neuropathol. Exp. Neurol 58 (1999) 1099-1110
69. Mersiyanova I.V., Perepelov A.V., Polyakov A.V., Sitnikov V.F., Dadali E.L., Oparin R.B., Petrin A.N., and Evgrafov O.V. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet 67 (2000) 37-46
70. Nguyen M.D., Lariviere R.C., and Julien J.P. Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1. Proc. Natl Acad. Sci. USA 97 (2000) 12306-12311
71. Nguyen M.D., Julien J.P., and Rivest S. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. Ann. Neurol 50 (2001) 630-639
72. Nguyen M.D., Lariviere R.C., and Julien J.-P. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30 (2001) 135-147
73. Nguyen M.D., Julien J.P., and Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration?. Nat. Rev. Neurosci 3 (2002) 216-227
74. Nguyen M.D., Mushynski W.E., and Julien J.P. Cycling at the interface between neurodevelopment and neurodegeneration. Cell Death Differ 9 (2002) 1294-1306
75. Nguyen M.D., Boudreau M., Kriz J., Couillard-Despres S., Kaplan D.R., and Julien J.P. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1. J. Neurosci 23 (2003) 2131-2140
76. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Van Den Bosch L., Cashman N., Fujisawa H., Drost M.R., Sciot R., Bruyninckx F., Hicklin D.J., Ince C., Gressens P., Lupu F., Plate K.H., Robberecht W., Herbert J.M., Collen D., and Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28 (2001) 131-138
77. Park D.S., Morris E.J., Stefanis L., Troy C.M., Shelanski M.L., Geller H.M., and Greene L.A. Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress. J. Neurosci 18 (1998) 830-840
78. Pasinelli P., Borchelt D.R., Houseweart M.K., Cleveland D.W., and Brown Jr. R.H. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc. Natl Acad. Sci. USA 95 (1998) 15763-15768
79. Pasinelli P., Houseweart M.K., Brown Jr. R.H., and Cleveland D.W. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu, Zn superoxide-dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 97 (2000) 13901-13906
80. Patrick G.N., Zukerberg L., Nikolic M., De la Monte S., Dikkes P., and Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402 (1999) 615-622
81. Pei J.J., Grundke-Iqbal I., Iqbal K., Bogdanovic N., Winblad B., and Cowburn R.F. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res 797 (1998) 267-277
82. Pramatarova A., Laganiere J., Roussel J., Brisebois K., and Rouleau G.A. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci 21 (2001) 3369-3374
83. Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L., Tokito M., Mann E., Floeter M.K., Bidus K., Drayna D., Oh S.J., Brown Jr. R.H., Ludlow C.L., and Fischbeck K.H. Mutant dynactin in motor neuron disease. Nat Genet 33 (2003) 455-456
84. Rao M.V., Houseweart M.K., Williamson T.L., Crawford T.O., Folmer J., and Cleveland D.W. Neurofilament-dependent radial growth of motor axons and axonal organization of neurofilaments does not require the neurofilament heavy subunit (NF-H) or its phosphorylation. J. Cell Biol 143 (1998) 171-181
85. Raoul C., Estevez A.G., Nishimune H., Cleveland D.W., DeLapeyriere O., Henderson C.E., Haase G., and Pettmann B. Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations. Neuron 35 (2002) 1067-1083
86. Reaume A.B., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., Wilcox H.M., Flood D.G., Beal M.F., Brown R.H.J., Scott R.W., and Snider W.D. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet 13 (1996) 43-47
87. Robertson J., Beaulieu J.M., Doroudchi M.M., Durham H.D., Julien J.-P., and Mushynski W.E. Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-alpha. J. Cell Biol 155 (2001) 217-226
88. Robertson J., Kriz J., Nguyen M.D., and Julien J.P. Pathways to motor neuron degeneration in transgenic mouse models. Biochimie 84 (2002) 1151-1160
89. Robertson J., Doroudchi M.M., Nguyen M.D., Durham H.D., Strong M.J., Shaw G., Julien J.-P., and Mushynski W.E. A neurotoxic peripherin splice variant in a mouse model of ALS. J. Cell Biol 160 (2003) 939-949
90. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Reagan J.P., Deng H.-X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., Van den Bergh R., Hung W.-Y., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericak-Vance M.A., Haines J., Rouleau G.A., Gusella J.S., Horvitz H.R., and Brown R.H. Mutation in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
91. Rouleau G.A., Clarke A.W., Rooke K., Pramatarova A., Krizus A., Suchowersky O., Julien J.-P., and Figlewicz D.A. SOD1 mutation is associated with accumulations of neurofilaments in amyotrophic lateral sclerosis. Ann. Neurol 39 (1996) 128-131
92. Subramaniam J.R., Lyons W.E., Liu J., Bartnikas T.B., Rothstein J., Price D.L., Cleveland D.W., Gitlin J.D., and Wong P.C. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci 5 (2002) 301-307
93. Tomkins J., Usher P., Slade J.Y., Ince P.G., Curtis A., Bushby K., and Shaw P.J. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). Neuroreport 9 (1998) 3967-3970
94. Tu P.H., Raju P., Robinson K.A., Gurney M.E., Trojanowski J.Q., and Lee V.M. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl Acad. Sci USA 93 (1996) 3155-3160
95. Van Den Bosch L., Tilkin P., Lemmens G., and Robberecht W. Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport 13 (2002) 1067-1070
96. Vukosavic S., Dubois-Dauphin M., Romero N., and Przedborski S. Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem 73 (1999) 2460-2468
97. Wang, J, Xu, G, Gonzales, V, Coonfield, M, Fromholt, D, Copeland, NG, Jenkins, NA, Borchelt, DR () Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site.
98. Wang J., Xu G., and Borchelt D.R. High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation. Neurobiol. Dis 9 (2002) 139-148
99. Wang L.J., Lu Y.Y., Muramatsu S., Ikeguchi K., Fujimoto K., Okada T., Mizukami H., Matsushita T., Hanazono Y., Kume A., Nagatsu T., Ozawa K., and Nakano I. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J. Neurosci 22 (2002) 6920-6928
100. Wiedau-Pazos M., Goto J.J., Rabizadeh S., Gralla E.D., Roe J.A., Valentine J.S., and Bredesen D.E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271 (1996) 515-518
101. Williamson T.L., and Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci 2 (1999) 50-56
102. Williamson T.L., Bruijn L.I., Zhu Q., Anderson K.L., Anderson S.D., Julien J.P., and Cleveland D.W. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc. Natl Acad. Sci. USA 95 (1998) 9631-9636
103. Wong N.K.Y., He B.P., and Strong M.J. Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J. Neuropathol. Exp. Neurol 59 (2000) 972-982
104. Wong P.C., Marszalek J., Crawford T.O., Xu Z., Hsieh S.T., Griffin J.W., and Cleveland D.W. Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilamentous accumulation in motor neurons. J. Cell Biol 130 (1995) 1413-1422
105. Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., and Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14 (1994) 1105-1116
106. Xu Z., Cork L.C., Griffin J.W., and Cleveland D.W. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 73 (1993) 23-33
107. Yamaguchi H., Ishiguro K., Uchida T., Takashima A., Lemere C.A., and Imahori K. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol. (Berl) 92 (1996) 232-241
108. Yang Y., Hentati A., Deng H.X., Dabbagh O., Sasaki T., Hirano M., Hung W.Y., Ouahchi K., Yan J., Azim A.C., Cole N., Gascon G., Yagmour A., Ben-Hamida M., Pericak-Vance M., Hentati F., and Siddique T. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet 29 (2001) 160-165
109. Zhang B., Tu P., Abtahian F., Trojanowski J.Q., and Lee V.M. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol 139 (1997) 1307-1315
110. Zhang W., Narayanan M., and Friedlander R.M. Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS. Ann. Neurol 53 (2003) 267-270
111. Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., Yang H.W., Terada S., Nakata T., Takei Y., Saito M., Tsuji S., Hayashi Y., and Hirokawa N. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105 (2001) 587-597
112. Zhu Q., Couillard-Despres S., and Julien J.-P. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp. Neurol 148 (1997) 299-316
113. Zhu Q., Lindenbaum M., Levavasseur F., Jacomy H., and Julien J.-P. Disruption of the NF-H gene increases axonal microtuble content and velocity of neurofilament transport: relief of axonopathy resulting from the toxin beta, beta-iminodipropionitrile. J. Cell Biol 143 (1998) 183-193
114. Zhu S., Stavrovskaya G., Drozda M., Kim B.Y., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu du C., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., and Friedlander R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417 (2002) 74-78